1
Jacobs, Maartje S, Schouten, Jeroen F, de Boer, Pieter T, Hoffmann, Mikael, Levin, Lars-Åke, Postma, Maarten J
Veröffentlicht in: Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528;
2018
Veröffentlicht in: Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528;
2018
2
Jacobs, M S, van Leent, M W J, Tieleman, R G, Jansman, F G A, Cao, Q, Postma, M J, van Hulst, M
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
3
van Hulst, Marinus, Stevanovic, Jelena, Jacobs, Maartje S, Tieleman, Robert G, Kappelhoff, Bregt, Postma, Maarten J
Veröffentlicht in: van Hulst , M , Stevanovic , J , Jacobs , M S , Tieleman , R G , Kappelhoff , B & Postma , M J 2018 , ' The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands ' , Journal of Medical Economics , vol. 21 , no. 1 , pp. 38-46 . https://doi.org/10.1080/13696998.2017.1372222;
2018
Veröffentlicht in: van Hulst , M , Stevanovic , J , Jacobs , M S , Tieleman , R G , Kappelhoff , B & Postma , M J 2018 , ' The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands ' , Journal of Medical Economics , vol. 21 , no. 1 , pp. 38-46 . https://doi.org/10.1080/13696998.2017.1372222;
2018
4
Le, H.H., Pechlivanoglou, P., Postma, M.J.
Veröffentlicht in: Le , H H , Pechlivanoglou , P & Postma , M J 2013 , ' Indirect treatment comparison and economic evaluation of novel oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in the Netherlands ' , Value in Health , vol. 16 , no. 7 , pp. A514 . https://doi.org/10.1016/j.jval.2013.08.1213;
2013
Veröffentlicht in: Le , H H , Pechlivanoglou , P & Postma , M J 2013 , ' Indirect treatment comparison and economic evaluation of novel oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in the Netherlands ' , Value in Health , vol. 16 , no. 7 , pp. A514 . https://doi.org/10.1016/j.jval.2013.08.1213;
2013